array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "Gsk Consumer Health, Inc."
["slug"]=>
string(32) "4abba-us-gsk-consumer-health-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204"
["description"]=>
string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company."
["address_street"]=>
string(28) "184 Liberty Corner Rd Ste 78"
["address_place"]=>
string(6) "Warren"
["address_region"]=>
string(10) "New Jersey"
["founding_date"]=>
string(10) "1994-02-28"
["website_domain"]=>
string(7) "gsk.com"
["website_url"]=>
string(19) "https://www.gsk.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(449)
}
["articles"]=>
array(5) {
[0]=>
array(7) {
["title_en"]=>
string(62) "Mutual Advisors LLC Purchases 452 Shares of GSK plc (NYSE:GSK)"
["snippet_en"]=>
string(219) "Mutual Advisors LLC boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission."
["url"]=>
string(104) "https://www.defenseworld.net/2024/03/29/mutual-advisors-llc-purchases-452-shares-of-gsk-plc-nysegsk.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5e6582b5-a950-4b28-8346-d30754db91b5"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-03-29"
["categories"]=>
array(6) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(11) "Regulations"
[3]=>
string(15) "Market Movement"
[4]=>
string(18) "General Investment"
[5]=>
string(12) "Stock Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(127) "Major Pharmaceutical Companies Adapt to Changing Consumer Health Market through Divestments and Strategic Shifts - News Biggest"
["snippet_en"]=>
string(156) "Pfizer is selling approximately 630 million shares of Haleon, which will lower its stake in the company from 32% to around 24%. This transaction is expected"
["url"]=>
string(137) "https://newsbiggest.com/major-pharmaceutical-companies-adapt-to-changing-consumer-health-market-through-divestments-and-strategic-shifts/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/eb0e8b0b-fd0c-42b6-abb5-5655bb4dc43a"
["source"]=>
string(15) "newsbiggest.com"
["publication_date"]=>
string(10) "2024-03-18"
["categories"]=>
array(6) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(11) "Acquisition"
[2]=>
string(18) "General Investment"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(8) "spin-off"
[5]=>
string(12) "Stock Market"
}
}
[2]=>
array(7) {
["title_en"]=>
string(51) "JPMorgan leaves GSK at 'Underweight' - target 1450p"
["snippet_en"]=>
string(81) "Reports, analysis and comments on the financial markets with a German perspective"
["url"]=>
string(93) "https://www.boersen-zeitung.de/ticker/jpmorgan-belaesst-gsk-auf-underweight-ziel-1450-pence-2"
["image_url"]=>
NULL
["source"]=>
string(18) "boersen-zeitung.de"
["publication_date"]=>
string(10) "2024-01-05"
["categories"]=>
array(2) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(12) "Board Change"
}
}
[3]=>
array(7) {
["title_en"]=>
string(38) "JPMORGAN upgrades GSK to 'Underweight'"
["snippet_en"]=>
string(264) "January 5, 2024 - The US bank JPMorgan has left GSK's rating at 'Underweight' with a price target of 1,450 pence ahead of quarterly figures. The pharmaceutical company is likely to present a solid report overall, wrote analyst James Gordon in a report on Friday..."
["url"]=>
string(82) "https://www.wallstreet-online.de/nachricht/17679123-jpmorgan-stuft-gsk-underweight"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6112e08c-4a54-4043-bc51-11ba58f7dafe"
["source"]=>
string(20) "wallstreet-online.de"
["publication_date"]=>
string(10) "2024-01-05"
["categories"]=>
array(3) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(51) "Better high-yield buy: Phoenix Group vs M&G shares?"
["snippet_en"]=>
string(132) "Which is the better long-term income buy, M&G or Phoenix Group shares? It's a tricky choice, and I wonder if I should just buy both?"
["url"]=>
string(83) "https://www.fool.co.uk/2023/11/20/better-high-yield-buy-phoenix-group-vs-mg-shares/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1f407934-5a79-4150-a45f-a415bf8e9463"
["source"]=>
string(10) "fool.co.uk"
["publication_date"]=>
string(10) "2023-11-20"
["categories"]=>
array(5) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(21) "Shareholders Feedback"
[2]=>
string(15) "Market Movement"
[3]=>
string(16) "Share Repurchase"
[4]=>
string(12) "Stock Market"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(28)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(26)
}
[3]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(20)
}
[5]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(18)
}
[6]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(17)
}
[7]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(16)
}
[8]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(15)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(14)
}
[10]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(8)
}
[19]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(6)
}
[22]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(6)
}
[23]=>
array(2) {
["name"]=>
string(6) "Crisis"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(21) "Cultural developments"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(6)
}
[27]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(5)
}
}
}
4abba-us-gsk-consumer-health-inc
Gsk Consumer Health, Inc.
Location
New Jersey
Founded
1994-02-28
Website
https://www.gsk.com
Articles
449 Articles
Category
Pharmaceutical Preparations
Description
GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company.
Mutual Advisors LLC boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
Pfizer is selling approximately 630 million shares of Haleon, which will lower its stake in the company from 32% to around 24%. This transaction is expected
January 5, 2024 - The US bank JPMorgan has left GSK's rating at 'Underweight' with a price target of 1,450 pence ahead of quarterly figures. The pharmaceutical company is likely to present a solid report overall, wrote analyst James Gordon in a report on Friday...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
